Home / Resource Library / Zanubrutinib in Japanese treatment‑naive and relapsed/refractory patients with Waldenstrom macroglobulinemia and CLL/SLLZanubrutinib in Japanese treatment‑naive and relapsed/refractory patients with Waldenstrom macroglobulinemia and CLL/SLL